Maurizio Guida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maurizio Guida has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Rachele Canelli
ENT Audiology and Phoniatric Unit, University Hospital of Pisa, Pisa, Italy
3 shared publications - Henricus P.M. Kunst
Dutch Academic Alliance Skull Base Pathology, Radboud University Medical Center, Maastricht University Medical Center+, Nijmegen/Maastricht, The Netherlands
2 shared publications - Paola Pardini
Dutch Academic Alliance Skull Base Pathology, Radboud University Medical Center, Maastricht University Medical Center+, Nijmegen/Maastricht, The Netherlands
2 shared publications - Anna Chiara Stellato
Department of Otorhinolaryngology, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
1 shared publication - Cesare Chiapperini
Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy
1 shared publication - Domenico Minervini
Department of Otorhinolaryngology, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
1 shared publication
Latest Publications
- Open Access
- 29 March 2024
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 20 (2) , 186-188
Intratympanic Gentamicin Injection for Endolymphatic Hydrops After Cochlear Implantation
Endolymphatic hydrops has been documented as a possible complication of cochlear implantation; however, few studies have addressed its treatment. We describe the first case ever reported of delayed endolymphatic hydrops after a cochlear implant successfully treated with intratympanic gentamicin injection. A detailed discussion of this case with a focus on its management and outcomes will be provided in comparison with literature data. The intratympanic gentamicin injection has been demonstrated to be an effective treatment for symptomatic endolymphatic hydrops after cochlear implantation. We advocate further studies to validate this strategy as a promising alternative to surgical labyrinthectomy. Cite this article as: Canzi P, Carlotto E, Quaglieri S, et al. Intratympanic gentamicin injection for endolymphatic hydrops after cochlear implantation. J Int Adv Otol. 2024;20(2):186-188.
- 29 March 2024
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 20 (2) , 186-188
Open AccessIntratympanic Gentamicin Injection for Endolymphatic Hydrops After Cochlear Implantation
Endolymphatic hydrops has been documented as a possible complication of cochlear implantation; however, few studies have addressed its treatment. We describe the first case ever reported of delayed endolymphatic hydrops after a cochlear implant successfully treated with intratympanic gentamicin injection. A detailed discussion of this case with a focus on its management and outcomes will be provided in comparison with literature data. The intratympanic gentamicin injection has been demonstrated to be an effective treatment for symptomatic endolymphatic hydrops after cochlear implantation. We advocate further studies to validate this strategy as a promising alternative to surgical labyrinthectomy. Cite this article as: Canzi P, Carlotto E, Quaglieri S, et al. Intratympanic gentamicin injection for endolymphatic hydrops after cochlear implantation. J Int Adv Otol. 2024;20(2):186-188.
- Open Access
- 1 September 2022
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 18 (5) , 447-450
Sensorineural Hearing Impairment Recovery after Transmastoidal Surgery for a Petrous Apex Cholesterol Granuloma: A Case Report
Cholesterol granulomas are the most common primary lesions of the petrous apex. Although their benign character, impingement of critical neurovascular structures can cause significant symptomatology such as hearing impairment. We present unique results after treatment of a cholesterol granuloma located in the petrous apex causing sensorineural hearing impairment. A transmastoidal approach was performed using an intraoperative computed tomography-guided navigation system. The video, which is included for reference, illustrates clear drainage of the cyst and drain positioning. The hearing improved completely in the lower frequencies at 500 and 1000 Hz and with a 19 dB improvement in overall bone conduction in the affected ear. Cite this article as: van Keulen S, Szweryn WJ, Jansen TTG, Bekkers S, Kunst HPM. Sensorineural hearing impairment recovery after transmastoidal surgery for a petrous apex cholesterol granuloma: A case report. J Int Adv Otol. 2022;18(5):447-450.
- 1 September 2022
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 18 (5) , 447-450
Open AccessSensorineural Hearing Impairment Recovery after Transmastoidal Surgery for a Petrous Apex Cholesterol Granuloma: A Case Report
Cholesterol granulomas are the most common primary lesions of the petrous apex. Although their benign character, impingement of critical neurovascular structures can cause significant symptomatology such as hearing impairment. We present unique results after treatment of a cholesterol granuloma located in the petrous apex causing sensorineural hearing impairment. A transmastoidal approach was performed using an intraoperative computed tomography-guided navigation system. The video, which is included for reference, illustrates clear drainage of the cyst and drain positioning. The hearing improved completely in the lower frequencies at 500 and 1000 Hz and with a 19 dB improvement in overall bone conduction in the affected ear. Cite this article as: van Keulen S, Szweryn WJ, Jansen TTG, Bekkers S, Kunst HPM. Sensorineural hearing impairment recovery after transmastoidal surgery for a petrous apex cholesterol granuloma: A case report. J Int Adv Otol. 2022;18(5):447-450.
- Open Access
- 1 September 2022
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 18 (5) , 451-454
Retrofacial Approach for Cochlear Implantation in Chronic Otitis Media: A Case Report*
Cochlear implantation is anatomically more difficult in postoperative ears than in normal ears due to chronic otitis media. In cochlear implantation after canal wall down mastoidectomy, the electrodes must be protected. We report a case of cochlear implantation with partial mastoid obliteration using a retrofacial approach in an 81-year-old woman. Bilateral tympanoplasty was performed for bilateral chronic otitis media, but no improvement in hearing was observed. Hearing aids were used, but their effect was insufficient and cochlear implantation was needed. Since the patient was an older adult with diabetes, it was necessary to avoid the risk of wound infection associated with fat harvesting from the abdomen, which is necessary for overclosure of the external ear. Therefore, we chose to perform partial mastoid obliteration using a retrofacial approach to ensure the prevention of electrode exposure. One year after surgery, the electrode had not been exposed or infected. The ear canal was preserved, and the eardrum could be observed. Although long-term follow-up is required, this approach may be useful for cochlear implantation in patients with chronic otitis media after canal wall down mastoidectomy. Cite this article as: Furuki S, Sano H, Yamashita T. Retrofacial approach for cochlear implantation in chronic otitis media: A case report. J Int Adv Otol. 2022;18(5):451-454.
- 1 September 2022
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 18 (5) , 451-454
Open AccessRetrofacial Approach for Cochlear Implantation in Chronic Otitis Media: A Case Report*
Cochlear implantation is anatomically more difficult in postoperative ears than in normal ears due to chronic otitis media. In cochlear implantation after canal wall down mastoidectomy, the electrodes must be protected. We report a case of cochlear implantation with partial mastoid obliteration using a retrofacial approach in an 81-year-old woman. Bilateral tympanoplasty was performed for bilateral chronic otitis media, but no improvement in hearing was observed. Hearing aids were used, but their effect was insufficient and cochlear implantation was needed. Since the patient was an older adult with diabetes, it was necessary to avoid the risk of wound infection associated with fat harvesting from the abdomen, which is necessary for overclosure of the external ear. Therefore, we chose to perform partial mastoid obliteration using a retrofacial approach to ensure the prevention of electrode exposure. One year after surgery, the electrode had not been exposed or infected. The ear canal was preserved, and the eardrum could be observed. Although long-term follow-up is required, this approach may be useful for cochlear implantation in patients with chronic otitis media after canal wall down mastoidectomy. Cite this article as: Furuki S, Sano H, Yamashita T. Retrofacial approach for cochlear implantation in chronic otitis media: A case report. J Int Adv Otol. 2022;18(5):451-454.
- Open Access
- 1 July 2022
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 18 (4) , 302-307
Bone-Anchored Hearing Aids Fitted According to NAL and DSL Procedures in Adults with Mixed Hearing Loss
BACKGROUND: Bone-anchored hearing aids represent a valid alternative for patients with conductive/mixed hearing loss who cannot use hear- ing aids. To date, these devices have given good audiological results, thanks to various fitting prescription programs (i.e., National Acoustic Laboratories and Desired Sensation Level). The aim of this study is to compare 2 types of fitting algorithms (National Acoustic Laboratories and Desired Sensation Level) implemented for bone-anchored hearing devices. METHODS: We retrospectively enrolled 10 patients followed at our operative unit, suffering from bilateral symmetrical mixed hearing loss and who underwent bone-anchored hearing aid implantation. All patients experienced each prescriptive procedure, National Acoustic Laboratories and Desired Sensation Level, for 7 months (on average), and they were subjected to audiological tests and questionnaires to evaluate the best program. RESULTS: National Acoustic Laboratories and Desired Sensation Level prescriptions yielded similar results. Desired Sensation Level allowed less amplification of the low frequencies than the National Acoustic Laboratories prescription, and these differences were the only statistically sig- nificant. Desired Sensation Level allowed better disyllabic word and sentence recognition scores only in quiet and not in noisy conditions. The subjective questionnaires showed similar results. At the end of the trial sessions, more patients (60%) definitively chose the Desired Sensation Level program for their device. These patients were those with a worse hearing threshold. CONCLUSION: The 2 prescriptive programs allowed similar results although patients with a worse threshold seem to prefer the DSL program. This is the first evaluation of the 2 prescriptive programs, National Acoustic Laboratories versus Desired Sensation Level, for bone conduction devices available in the literature. Further studies are needed to confirm this initial finding. Cite this article as: Bruschini L, Canelli R, Guida M, et al. Bone-anchored hearing aids fitted according to NAL and DSL procedures in adults with mixed hearing loss. J Int Adv Otol. 2022;18(4):302-307.
- 1 July 2022
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 18 (4) , 302-307
Open AccessBone-Anchored Hearing Aids Fitted According to NAL and DSL Procedures in Adults with Mixed Hearing Loss
BACKGROUND: Bone-anchored hearing aids represent a valid alternative for patients with conductive/mixed hearing loss who cannot use hear- ing aids. To date, these devices have given good audiological results, thanks to various fitting prescription programs (i.e., National Acoustic Laboratories and Desired Sensation Level). The aim of this study is to compare 2 types of fitting algorithms (National Acoustic Laboratories and Desired Sensation Level) implemented for bone-anchored hearing devices. METHODS: We retrospectively enrolled 10 patients followed at our operative unit, suffering from bilateral symmetrical mixed hearing loss and who underwent bone-anchored hearing aid implantation. All patients experienced each prescriptive procedure, National Acoustic Laboratories and Desired Sensation Level, for 7 months (on average), and they were subjected to audiological tests and questionnaires to evaluate the best program. RESULTS: National Acoustic Laboratories and Desired Sensation Level prescriptions yielded similar results. Desired Sensation Level allowed less amplification of the low frequencies than the National Acoustic Laboratories prescription, and these differences were the only statistically sig- nificant. Desired Sensation Level allowed better disyllabic word and sentence recognition scores only in quiet and not in noisy conditions. The subjective questionnaires showed similar results. At the end of the trial sessions, more patients (60%) definitively chose the Desired Sensation Level program for their device. These patients were those with a worse hearing threshold. CONCLUSION: The 2 prescriptive programs allowed similar results although patients with a worse threshold seem to prefer the DSL program. This is the first evaluation of the 2 prescriptive programs, National Acoustic Laboratories versus Desired Sensation Level, for bone conduction devices available in the literature. Further studies are needed to confirm this initial finding. Cite this article as: Bruschini L, Canelli R, Guida M, et al. Bone-anchored hearing aids fitted according to NAL and DSL procedures in adults with mixed hearing loss. J Int Adv Otol. 2022;18(4):302-307.